126 related articles for article (PubMed ID: 25302081)
1. Association and interaction analysis of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han population.
Wu HH; Liu NJ; Yang Z; Tao XM; Du YP; Wang XC; Lu B; Zhang ZY; Hu RM; Wen J
Diabetol Metab Syndr; 2014; 6(1):107. PubMed ID: 25302081
[TBL] [Abstract][Full Text] [Related]
2. Correlation Between
Du F; Yang KJ; Piao LS
Open Life Sci; 2019 Jan; 14():43-52. PubMed ID: 33817136
[TBL] [Abstract][Full Text] [Related]
3. Systematic Meta-analysis Revealed an Association of PGC-1
Xia W; Chen N; Peng W; Jia X; Yu Y; Wu X; Gao H
Dis Markers; 2019; 2019():2970401. PubMed ID: 30944665
[TBL] [Abstract][Full Text] [Related]
4. Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover.
Huang M; Claussnitzer M; Saadat A; Coral DE; Kalamajski S; Franks PW
Diabetologia; 2023 Jul; 66(7):1289-1305. PubMed ID: 37171500
[TBL] [Abstract][Full Text] [Related]
5. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population.
Zhu S; Liu Y; Wang X; Wu X; Zhu X; Li J; Ma J; Gu HF; Liu Y
Diabetes Res Clin Pract; 2009 Dec; 86(3):168-72. PubMed ID: 19828207
[TBL] [Abstract][Full Text] [Related]
7. Association between the PPARGC1A Gly482Ser polymorphism and muscle fitness in Chinese schoolchildren.
Wei Q
PLoS One; 2023; 18(4):e0284827. PubMed ID: 37104269
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor γ coactivator-1 alpha rs8192678 (Gly482Ser) variant and hepatitis B virus clearance.
Abounouh K; Tanouti IA; Ouladlahsen A; Tahiri M; Badre W; Dehbi H; Sarih M; Benjelloun S; Pineau P; Ezzikouri S
Infect Dis (Lond); 2023 Sep; 55(9):614-624. PubMed ID: 37376899
[TBL] [Abstract][Full Text] [Related]
9. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes].
Su Y; Peng SB; Li ZQ; Huang QY
Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997
[TBL] [Abstract][Full Text] [Related]
10. Association of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha Coding Variants with Hepatocellular Carcinoma Risk in the Moroccan Population: A Case-Control Study.
Tanouti IA; Fellah H; El Fihry R; Zerrad C; Abounouh K; Tahiri M; Belkouchi A; Badre W; Pineau P; Benjelloun S; Ezzikouri S
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3689-3696. PubMed ID: 38019226
[TBL] [Abstract][Full Text] [Related]
11. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
12.
Yvert T; Miyamoto-Mikami E; Tobina T; Shiose K; Kakigi R; Tsuzuki T; Takaragawa M; Ichinoseki-Sekine N; Pérez M; Kobayashi H; Tanaka H; Naito H; Fuku N
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32867330
[No Abstract] [Full Text] [Related]
13. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population.
Jing C; Xueyao H; Linong J
Endocrine; 2012 Oct; 42(2):307-20. PubMed ID: 22391941
[TBL] [Abstract][Full Text] [Related]
14. Influence of Peroxisome Proliferator-Activated Receptor (PPAR)-gamma Coactivator (PGC)-1 alpha gene rs8192678 polymorphism by gender on different health-related parameters in healthy young adults.
Montes-de-Oca-García A; Corral-Pérez J; Velázquez-Díaz D; Perez-Bey A; Rebollo-Ramos M; Marín-Galindo A; Gómez-Gallego F; Calderon-Dominguez M; Casals C; Ponce-González JG
Front Physiol; 2022; 13():885185. PubMed ID: 35936915
[TBL] [Abstract][Full Text] [Related]
15. Gene-environment interaction in chronic kidney disease among people with type 2 diabetes from The Malaysian Cohort project: a case-control study.
Ahmad N; Shah SA; Abdul Gafor AH; Abdul Murad NA; Kamaruddin MA; Abd Jalal N; Ismail N; Alias MR; Jamal R
Diabet Med; 2020 Nov; 37(11):1890-1901. PubMed ID: 32012348
[TBL] [Abstract][Full Text] [Related]
16. Assessment of
Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
[TBL] [Abstract][Full Text] [Related]
17. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
[TBL] [Abstract][Full Text] [Related]
18. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population.
Jemaa Z; Kallel A; Sleimi C; Mahjoubi I; Feki M; Ftouhi B; Slimane H; Jemaa R; Kaabachi N
Diabetes Metab Syndr; 2015; 9(4):316-9. PubMed ID: 25470625
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the association between a polymorphism of KCNJ11 and diabetic retinopathy in a Chinese Han population.
Liu NJ; Wu HH; Li YL; Yang Z; Tao XM; Du YP; Wang XC; Lu B; Zhang ZY; Hu RM; Wen J
Eur J Med Res; 2015 Jan; 20(1):3. PubMed ID: 25573672
[TBL] [Abstract][Full Text] [Related]
20. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis.
Yang Y; Mo X; Chen S; Lu X; Gu D
Diabetes Metab Res Rev; 2011 Feb; 27(2):177-84. PubMed ID: 21294239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
